Dona Fleishaker
Impact in
- Rheumatology top 1%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 23
- Rheumatoid Arthritis Research and Therapies 19
- Spondyloarthritis Studies and Treatments 17
- Systemic Lupus Erythematosus Research 3
- Hematology 17
- Autoimmune and Inflammatory Disorders Research 17
- Co-authors
- Keith S. KanikSujatha MenonDésirée van der HeijdeAtul DeodharThijs HendrikxJames Cheng‐Chung WeiEdit DrescherDavid Li
- Journals
- Annals of the Rheumatic Diseases (7 papers)Rheumatology and Therapy (3 papers)The Pediatric Infectious Disease Journal (2 papers)Arthritis Research & Therapy (2 papers)The Lancet Rheumatology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Dona Fleishaker
27 papers receiving 888 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Rheumatology 604
- Hematology 307
- Immunology 359
- Microbiology 7
- Clinical Biochemistry 55
Countries citing papers authored by Dona Fleishaker
This map shows the geographic impact of Dona Fleishaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dona Fleishaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dona Fleishaker more than expected).
Fields of papers citing papers by Dona Fleishaker
This network shows the impact of papers produced by Dona Fleishaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dona Fleishaker. The network helps show where Dona Fleishaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Dona Fleishaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19 Hit paper breakdown → | 2024 | 50 |
| 3 | 2023 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 2 | |
| 6 | Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study | 2021 | 0 |
| 7 | Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study Hit paper breakdown → | 2021 | 159 |
| 8 | 2021 | 27 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 15 | |
| 12 | 2020 | 48 | |
| 13 | Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study Hit paper breakdown → | 2017 | 272 |
| 14 | Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, up to 36 Months in Patients with Active Psoriatic Arthritis: Data from the Second Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study | 2017 | 2 |
| 15 | 2017 | 3 | |
| 16 | 2016 | 31 | |
| 17 | Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomized, Placebo-Controlled, Dose-Ranging Study | 2015 | 3 |
| 18 | 2012 | 51 | |
| 19 | 2003 | 48 | |
| 20 | 2003 | 56 |
About Dona Fleishaker
Dona Fleishaker is a scholar working on Rheumatology, Hematology, Clinical Biochemistry, Immunology and Infectious Diseases, having authored 28 papers that have together received 906 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (19 papers), Spondyloarthritis Studies and Treatments (17 papers), Autoimmune and Inflammatory Disorders Research (17 papers), Systemic Lupus Erythematosus Research (3 papers), Pharmaceutical studies and practices (3 papers), Bacterial Identification and Susceptibility Testing (2 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Rheumatology (604 citations), Hematology (307 citations), Immunology (359 citations), Microbiology (7 citations) and Clinical Biochemistry (55 citations). Dona Fleishaker has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Keith S. Kanik, Sujatha Menon, Désirée van der Heijde, Atul Deodhar, Thijs Hendrikx, James Cheng‐Chung Wei, Edit Drescher, David Li, Lara Fallon and Joseph Wu. Their work appears in journals such as Annals of the Rheumatic Diseases, Rheumatology and Therapy, The Pediatric Infectious Disease Journal, Arthritis Research & Therapy and The Lancet Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.